PROFUSA, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
PROFUSA, INC. (PFSA) had Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 1.00% as of 2022-08-16, per its S-1/A filed 2026-05-01.
Financial Statements › Notes › Income Taxes › Effective Income Tax Rate Reconciliation, Percent
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-05-01
- 2022-08-16: Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 1.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent |
|---|---|
| 2022-08-16 | 1.00% S-1/A · filed 2026-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |